The identification of a specific enrichment of EMT-associated proteins and immunomodulatory signals, such as PD-L1, within these EVs suggests that extracellular vimentin may be a key player in driving both cellular migration and immune evasion in the tumor microenvironment. The gene discussed is VIM; the disease is neoplasm.